Evidence map›Paper›PMID 25950001›Full record

ArticleBioMed research international2015

Alpha-mangostin attenuation of hyperglycemia-induced ocular hypoperfusion and blood retinal barrier leakage in the early stage of type 2 diabetes rats.

Amporn Jariyapongskul, Chonticha Areebambud, Sunit Suksamrarn, Chantana Mekseepralard

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
7.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 40 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Medicinal Potential ofMolecules (Basel, Switzerland) · 2020
    Review
  11. Review
  12. Alpha-mangostin decreased cellular senescence in human umbilical vein endothelial cells.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2020
    Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Amporn JariyapongskulDepartment of Physiology, Faculty of Medicine, Srinakharinwirot University, Bangkok 10110, Thailand.
Chonticha AreebambudBiomedical Science Program, Faculty of Medicine, Srinakharinwirot University, Bangkok 10110, Thailand.
Sunit SuksamrarnDepartment of Chemistry, Faculty of Science, Srinakharinwirot University, Bangkok 10110, Thailand.
Chantana MekseepralardDepartment of Microbiology, Faculty of Medicine, Srinakharinwirot University, Bangkok 10110, Thailand.
Srinakharinwirot University · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study examined effects of alpha-mangostin (α-MG) supplementation on the retinal microvasculature, including ocular blood flow (OBF) and blood-retinal barrier (BRB) permeability in a type 2 diabetic animal model. Male Sprague-Dawley rats were divided into four groups: normal control and diabetes with or without α-MG supplementation. Alpha-mangostin (200 mg/Kg/day) was administered by gavage feeding for 8 weeks. The effects of α-MG on biochemical and physiological parameters including mean arterial pressure (MAP), OBF, and BRB leakage were investigated. Additionally, levels of retinal malondialdehyde (MDA), advance glycation end products (AGEs), receptor of advance glycation end products (RAGE), tumour necrosis factor alpha (TNF-α), and vascular endothelial growth factor (VEGF) were evaluated. The elevated blood glucose, HbA1c, cholesterol, triglyceride, serum insulin, and HOMA-IR were observed in DM2 rats. Moreover, DM2 rats had significantly decreased OBF but statistically increased MAP and leakage of the BRB. The α-MG-treated DM2 rats showed significantly lower levels of retinal MDA, AGEs, RAGE, TNF-α, and VEGF than the untreated group. Interestingly, α-MG supplementation significantly increased OBF while it decreased MAP and leakage of BRB. In conclusion, α-MG supplementation could restore OBF and improve the BRB integrity, indicating its properties closely associated with antihyperglycemic, antioxidant, anti-inflammatory, and antiglycation activities.

Indexed as

AnimalsBlood GlucoseBlood-Retinal BarrierDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2Diabetic RetinopathyGlycated HemoglobinHumansHyperglycemiaMaleRatsTumor Necrosis Factor-alphaVascular Endothelial Growth Factor AXanthonesBlood GlucoseGlycated HemoglobinmangostinTumor Necrosis Factor-alphaVascular Endothelial Growth Factor AXanthones

Identifiers

PMID25950001
PMCPMC4407409
OpenAlexW2075642216

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.